DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

PF-06282999

Generic Name: PF-06282999

Drug Type: Small Molecule

Chemical Formula: C_₁₃H_₁₂ClN_₃O_₃S

CAS Number: 1435467-37-0

Unique Ingredient Identifier: YO3O4Q2NC8

Overview

Pf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects).

Background

Pf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model

Phase 1

Terminated

Posted: 2013/10/18

Sponsor:Pfizer

A Study To Test The Safety, Amount And Effects Of PF-06282999 In Healthy Overweight Adults And A Study To Test The Effects Of PF-06282999 On The Amount Of The Approved Drug, Midazolam, In Healthy Adults

Phase 1

Completed

Posted: 2012/10/15

Sponsor:Pfizer

A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects

Phase 1

Completed

Posted: 2012/06/25

Sponsor:Pfizer

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy